These findings suggest that tumor-induced CD45RA−CCR7− Treg subset suppresses CD8+ T-cell immunity in vivo dependent on IL-10 secretion and cell–cell contact mechanisms and thereby contribute to tumor growth and GC progression. The gene discussed is CD8A; the disease is neoplasm.